Business news from Ukraine

AGRITRADE UKRAINE PROJECT PRESENTS RESEARCH “ANALYSIS OF INSTITUTIONAL SUPPORT FOR EXPORTS AMONG ORGANIZATIONS OF AGRARIAN SECTOR”

The Ukrainian Chambers of Commerce and Industry and export organizations assess the opportunities for the export of Ukrainian products on a 10-point scale at 7.5, and note the need for state support for export activities, which should provide for financial, legal, communication and infrastructure direction.
According to the research “Analysis of institutional support for exports among organizations of the agrarian sector of Ukraine” of the Agritrade Ukraine project, the text of which is available to the Interfax-Ukraine agency, the average assessment of the opportunities for the export of Ukrainian products on a 10-point scale (where one is very poor opportunities, while ten is very good) by participants in the study was 7.5.
Among the main factors of such an assessment were named a high existing demand abroad, good qualifications and experience of industry employees, favorable agro-climatic conditions.
At the same time, the participants in the research noted that the implementation of the export potential is impossible in full due to a saturated competitive environment, insufficient level of harmonization of production and processing standards, the complexity and lack of information about the features of certification and the inertia of some domestic farmers.
More than three quarters of the organizations (77%) that that took part in the survey noted that they have established cooperation with companies from the EU countries. Among the main problems that arise in this process and become obstacles to cooperation, they named a small amount of quotas for certain types of agricultural products, non-compliance with quality standards and certification standards, a saturated competitive environment.
Assessing the compliance of domestic agricultural products and food products with European quality standards, almost three quarters of the respondents (72%) noted that they were more likely to comply, 12% of the survey participants were sure of absolute compliance.
Approximately one fifth of the organizations (22%) that took part in the survey can fully satisfy the requests of Ukrainian companies to establish trade relations with foreign companies and companies from the EU countries (that is, 90-100% of requests).
Among the main factors that affect the ability to satisfy the requests of Ukrainian companies to establish trade relations with foreign companies and companies from the EU countries, the survey participants most often named a lack of practical experience of employees, a lack of knowledge of business English and export-import legal framework, a limited access to market information (supply-demand), lack of analytical skills and tools, the volume of quotas for the export of certain types of agricultural products, limited and insufficient advertising and marketing budgets.

, , ,

DARNITSA PHARMACEUTICAL COMPANY INVESTS EUR 3.5 MLN IN DEVELOPMENT AND RESEARCH

Darnitsa pharmaceutical company in 2018 invested about EUR3.5 million in development and research (R&D), Dmytro Shymkiv, the head of the board of directors of Darnitsa Group, has said.
“Every year we invest about 10% of gross income in development and research. In 2018 the amount of such investments totaled EUR 3.5 million. In total, Darnitsa invested about EUR 200 million in development,” he said at a press conference in Kyiv.
Shymkiv said that in 2020-2022 Darnitsa plans to conduct 9-12 drug bioequivalence studies.
Since 2016, the company has completed eight such studies.
According to him, the development strategy of Darnitsa provides for three priority areas of the product portfolio: cardiology, neurological drugs, and pain therapy.
In 2019, the pharmaceutical company plans to bring 11 brands to the market, in 2020 some 14. In 2018, Darnitsa brought ten brands to the market.
Currently, the company’s product portfolio comprises 250 types of finished medicines.
Darnitsa pharmaceutical company is one of the ten largest pharmaceutical manufacturers in Ukraine and the top ten largest hospital suppliers. Its ultimate beneficiary is Hlib Zahoriy.

, , ,